Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

Evaluation of paediatric outpatient parenteral antibiotic therapy for septic arthritis and osteomyelitis

British Orthopaedic Association 2012 Annual Congress



Abstract

Purpose

To analyse the effectiveness of using outpatient management of paediatric bone and joint infections with parenteral antibiotic therapy in terms of its efficacy, safety and cost-effectiveness compared to prolonged inpatient treatment.

Method

Paediatric cases of septic arthritis or osteomyelitis were identified over a seven year (2004–2011) period in a regional teaching hospital. This included patients either treated as long-term inpatients or given outpatient parenteral antibiotic therapy. The outcome measures recorded included: whether treatment was successful, complications, and length of hospital stay. A cost analysis was also calculated.

Results

A total of 41 paediatric patients diagnosed with osteomyelitis or septic arthritis were reviewed, of which 8 were treated as inpatients during the course of their IV antibiotic therapy, and 33 were treated with outpatient parenteral antibiotic therapy (requiring a PICC line to be in situ).

The mean length of hospital stay for the inpatient group was 23 days, compared to 3.9 days for the outpatient group. The cost saving in terms of hospital stay is (19 × £464=) £8816. Treatment was effective in all groups. In terms of complications of therapy, there was 1 antibiotic-related case in the inpatient group, and 4 cases in the outpatient group of which 3 related to antibiotic side-effects and 1 related to the PICC line.

Conclusion

Outpatient treatment of paediatric bone and joint infections is both clinically and cost effective when compared to long stay inpatient management. It is safe, well tolerated and we advocate its adoption, wherever resources allow.